Could a molecule from Gila monster saliva silence the noise of addiction?
Physician Dhruv Khullar explores the unexpected potential of GLP-1 medications. This video examines how drugs like Ozempic, originally designed for diabetes, might move beyond weight management to address the neurological roots of craving.
The journey of GLP-1s, often called the 'moderation molecule,' began with a discovery in the saliva of the Gila monster. While these drugs are widely known for their role in treating diabetes and managing weight, their most profound impact may occur within the brain rather than the gut.
Khullar investigates whether these medications can quiet the relentless neurological noise associated with addiction. By tracing the winding path of these compounds, the talk explores the possibility of using GLPKs as a new frontier in addiction treatment.
Source: Dhruv Khullar: Can Ozempic end addiction?
